Ping Wang
Impact in
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
Papers in ⓘ
-
- Traditional Chinese Medicine Analysis 13
- Pharmacology 27
- Pharmacological Effects of Natural Compounds 18
- Berberine and alkaloids research 8
- Co-authors
- Nikola P. Pavletich (2 shared papers)Ning Zheng (2 shared papers)Philip D. Jeffrey (2 shared papers)Xianli Meng (23 shared papers)Deanna M. Koepp (1 shared paper)Michele Pagano (1 shared paper)Brenda A. Schulman (1 shared paper)Joan Conaway (1 shared paper)
- Journals
- Frontiers in Pharmacology (9 papers)Journal of Ethnopharmacology (6 papers)Evidence-based Complementary and Alternative Medicine (4 papers)Scientific Reports (3 papers)Molecules (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ping Wang
216 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Molecular Biology 3.6k
- Complementary and alternative medicine 394
- Pharmacology 415
- Cell Biology 566
- Oncology 837
Countries citing papers authored by Ping Wang
This map shows the geographic impact of Ping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Wang more than expected).
Fields of papers citing papers by Ping Wang
This network shows the impact of papers produced by Ping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Wang. The network helps show where Ping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 227 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex Hit paper breakdown → | 2002 | 1216 |
| 2 | Structure of a c-Cbl–UbcH7 Complex Hit paper breakdown → | 2000 | 707 |
| 3 | 2010 | 206 | |
| 4 | 2014 | 164 | |
| 5 | 2013 | 128 | |
| 6 | 2011 | 117 | |
| 7 | 2012 | 106 | |
| 8 | 2020 | 104 | |
| 9 | 1983 | 100 | |
| 10 | 2021 | 99 | |
| 11 | 2020 | 90 | |
| 12 | 2019 | 87 | |
| 13 | 2020 | 83 | |
| 14 | 2020 | 83 | |
| 15 | 2019 | 79 | |
| 16 | 2000 | 78 | |
| 17 | 2018 | 73 | |
| 18 | 2020 | 73 | |
| 19 | 2010 | 73 | |
| 20 | 2016 | 71 |
About Ping Wang
Ping Wang is a scholar working on Complementary and alternative medicine, Pharmacology, Analytical Chemistry, Pharmacology and Molecular Biology, having authored 227 papers that have together received 6.1k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (18 papers), Ubiquitin and proteasome pathways (17 papers), Natural product bioactivities and synthesis (16 papers), Traditional Chinese Medicine Analysis (13 papers), Phytochemistry and Biological Activities (12 papers), Analytical Chemistry and Chromatography (11 papers), Chromatography in Natural Products (10 papers) and Berberine and alkaloids research (8 papers). The work is most often cited by research in Molecular Biology (3.6k citations), Complementary and alternative medicine (394 citations), Pharmacology (415 citations), Cell Biology (566 citations) and Oncology (837 citations). Ping Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Nikola P. Pavletich, Ning Zheng, Philip D. Jeffrey, Xianli Meng, Deanna M. Koepp, Michele Pagano, Brenda A. Schulman, Joan Conaway, Stephen J. Elledge and Claire Chu. Their work appears in journals such as Frontiers in Pharmacology, Journal of Ethnopharmacology, Evidence-based Complementary and Alternative Medicine, Scientific Reports and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.